Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04182776 · ClinicalTrials.gov registry record
Fragility Fractures of the Pelvis (FFP)
A clinical trial of Pelvic Fracture, sponsored by AO Innovation Translation Center.
- Recruiting
- Registry status
- 420
- Enrollment target
- 10
- Study locations
NCT04182776: Recruiting study of Pelvic Fracture, sponsored by AO Innovation Translation Center.
NCT04182776 is a study of Pelvic Fracture that is actively recruiting participants, run by AO Innovation Translation Center. The registered enrollment target is 420 participants. The trial reports 10 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04182776, a study of Pelvic Fracture, is actively recruiting participants, sponsored by AO Innovation Translation Center.
- RECRUITING
- Registry status
- 420 participants
- Enrollment target
- 10
- Study locations
Study Summary
Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann. Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, functional and patient reported outcomes (PRO)s, radiological outcomes, and anticipated or procedure-related adverse events (i.e. complications).
Primary Outcome
Year of birth, Gender, Ethnicity, Height (cm) and Weight (kg) will be combined to report BMI in kg/m\^2
Conditions Studied
Study Locations (10)
Other
- The Ottawa Hospital - Civic Campus - Ottawa
- University Medical Center Hamburg Eppendorf - Hamburg
- University Hospital Leipzig - Leipzig
- University Medical Center Johannes Gutenberg-University - Mainz
- Queen Mary Hospital - Hong Kong
- Okayama medical hospital - Okayama
- University Medical Center Groningen - Groningen
- Radboud University Medical Center - Nijmegen
- Cantonal Hospital Lucerne - Lucerne
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-06 |
What NCT04182776 shows while recruiting
NCT04182776 is an observational study that tracks outcomes without assigning an intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pelvic Fracture appearing as the primary indexed condition, and to 0 interventions.
NCT04182776 lists 10 locations in 2 states (Other, Missouri).
Frequently Asked Questions
What is clinical trial NCT04182776 about?
NCT04182776 is a clinical study titled "Fragility Fractures of the Pelvis (FFP)". Prospective data will be collected in approximately 420 patients, above the age of 65, suffering from an FFP type fracture equal to or higher than type II, according to Rommens and Hofmann. Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data c...
What is the current status of trial NCT04182776?
This trial is currently recruiting. The enrollment target is 420 participants. The study started on 2022-03-01. Estimated completion is 2026-06.
What conditions does trial NCT04182776 study?
This clinical trial studies the following conditions: Pelvic Fracture.
Who is sponsoring clinical trial NCT04182776?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04182776 being conducted?
This trial has 10 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI